UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 33

of 'Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer'

33
TI
First-line Ceritinib Versus Chemotherapy in Patients With ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4)
AU
De Castro Jr G, Tan DS, Crino L, et al
SO
WCLC. 2016;PL03.07
 
AD